• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.

作者信息

Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, Lewis S, Lindley R, Neilson A, Thomas B, Wardlaw J

机构信息

Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland.

出版信息

Health Technol Assess. 2002;6(26):1-112. doi: 10.3310/hta6260.

DOI:10.3310/hta6260
PMID:12433319
Abstract
摘要

相似文献

1
A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.对英国国家医疗服务体系（NHS）中急性缺血性卒中溶栓和神经保护治疗的有效性、成本效益及实施障碍的系统评价。
Health Technol Assess. 2002;6(26):1-112. doi: 10.3310/hta6260.
2
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2003(3):CD000213. doi: 10.1002/14651858.CD000213.
3
Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation.急性心肌梗死直接血管成形术的临床疗效与成本效益：系统评价与经济学评估
Health Technol Assess. 2005 May;9(17):1-99, iii-iv. doi: 10.3310/hta9170.
4
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.急性缺血性卒中的溶栓治疗（不同剂量、给药途径和药物）
Cochrane Database Syst Rev. 2004 Oct 18(4):CD000514. doi: 10.1002/14651858.CD000514.pub2.
5
The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.多奈哌齐、卡巴拉汀、加兰他敏和美金刚用于治疗阿尔茨海默病的临床疗效及成本效益
Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. doi: 10.3310/hta10010.
6
Thrombolysis for acute ischaemic stroke.急性缺血性脑卒中的溶栓治疗
Cochrane Database Syst Rev. 2000(2):CD000213. doi: 10.1002/14651858.CD000213.
7
Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke.急性缺血性卒中的溶栓治疗（不同剂量、给药途径和药物）
Cochrane Database Syst Rev. 2000(2):CD000514. doi: 10.1002/14651858.CD000514.
8
Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review.多奈哌齐、卡巴拉汀和加兰他敏治疗阿尔茨海默病的临床疗效及成本效益：一项快速系统评价
Health Technol Assess. 2001;5(1):1-137. doi: 10.3310/hta5010.
9
Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke.己酮可可碱、丙戊茶碱和戊四氮用于急性缺血性卒中
Cochrane Database Syst Rev. 2004(3):CD000162. doi: 10.1002/14651858.CD000162.pub2.
10
Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.基于英国国家医疗服务体系（NHS）成本的模型评估重组组织型纤溶酶原激活剂溶栓治疗急性缺血性卒中的成本效益。
Stroke. 2004 Jun;35(6):1490-7. doi: 10.1161/01.STR.0000126871.98801.6E. Epub 2004 Apr 22.

引用本文的文献

1
Clinical and cost-effectiveness of clopidogrel resistance genotype testing after ischaemic stroke or transient ischaemic attack: a systematic review and economic model.缺血性卒中和短暂性脑缺血发作后氯吡格雷抵抗基因型检测的临床和成本效益：系统评价和经济模型。
Health Technol Assess. 2024 Sep;28(57):1-194. doi: 10.3310/PWCB4016.
2
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.基于血液生物标志物的工具对指导院前溶栓治疗脑卒中患者的潜在效率建模。
Eur J Health Econ. 2023 Jun;24(4):621-632. doi: 10.1007/s10198-022-01495-1. Epub 2022 Jul 27.
3
Secondary transfer of emergency stroke patients eligible for mechanical thrombectomy by air in rural England: economic evaluation and considerations.
英国农村地区符合机械取栓条件的急性卒中患者通过空中二次转运：经济评估与考量
Emerg Med J. 2021 Jan;38(1):33-39. doi: 10.1136/emermed-2019-209039. Epub 2020 Nov 10.
4
Health professionals' views on the barriers and enablers to evidence-based practice for acute stroke care: a systematic review.医疗专业人员对急性中风护理循证实践的障碍与促进因素的看法：一项系统综述
Implement Sci. 2017 Jun 5;12(1):74. doi: 10.1186/s13012-017-0599-3.
5
Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke.急性缺血性卒中使用支架取栓器进行机械取栓的成本-效用分析
Stroke. 2015 Sep;46(9):2591-8. doi: 10.1161/STROKEAHA.115.009396. Epub 2015 Aug 6.
6
Stroke: Stroke outcomes after 90 days—out of sight, out of mind?中风：90天后的中风结局——眼不见，心不烦？
Nat Rev Neurol. 2015 Apr;11(4):187-8. doi: 10.1038/nrneurol.2015.28. Epub 2015 Mar 10.
7
Alteplase for the treatment of acute ischaemic stroke: a NICE single technology appraisal; an evidence review group perspective.阿替普酶治疗急性缺血性脑卒中：英国国家卫生与临床优化研究所单一技术评估；证据审查小组观点
Pharmacoeconomics. 2015 Mar;33(3):225-33. doi: 10.1007/s40273-014-0233-z.
8
Estimating the payoffs from cardiovascular disease research in Canada: an economic analysis.估算加拿大心血管疾病研究的收益：一项经济分析。
CMAJ Open. 2013 Jul 25;1(2):E83-90. doi: 10.9778/cmajo.20130003. eCollection 2013 May.
9
Thrombolysis for acute ischaemic stroke.急性缺血性卒中的溶栓治疗
Cochrane Database Syst Rev. 2014 Jul 29;2014(7):CD000213. doi: 10.1002/14651858.CD000213.pub3.
10
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.急性缺血性脑卒中发病 6 h 内使用阿替普酶溶栓对长期结局的影响（第三次国际脑卒中试验 [IST-3]）：一项随机对照试验的 18 个月随访。
Lancet Neurol. 2013 Aug;12(8):768-76. doi: 10.1016/S1474-4422(13)70130-3. Epub 2013 Jun 21.